IKNA : Insider Transactions for Ikena Oncology, Inc. | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

Ikena Oncology, Inc. (IKNA)

$0.00 0.00 (0.00%) as of 4:30 Tue 11/30

Download

Exchange:

N/A

Security Type:

N/A

Shares Out:

48,260,000

Market Cap:

N/A

Last Volume:

0

Avg Vol:

0

52 Week Range:

$ - $

Level I Sector:

N/A

Level II Sector:

N/A

Level III Sector:

N/A

Member Indexes:

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : -

Guru Rank Value : -

Guru Occurances : -

Company Profile Ikena Oncology is a targeted oncology company developing medicines tailored to biomarker-defined patient groups. Co.'s programs are across the Hippo pathway, RAS pathway, and key immune signals in the tumor-microenvironment, with approaches to targeting both cancer driving targets and mechanisms of resistance to targeted therapies. Co.'s primary targeted oncology product candidate, IK-930, is an oral small molecule inhibitor of the transcriptional enhanced associate domain transcription factor in the Hippo signaling pathway. Co.'s clinical-stage programs also include product candidates in development to target immune signaling in the tumor microenvironment.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	351,167	351,167	351,167	351,167
Total Buy Value	$10,499,893	$10,499,893	$10,499,893	$10,499,893
Total People Bought	2	2	2	2
Total Buy Transactions	2	2	2	2
Total Shares Sold	0	0	0	0
Total Sell Value	$0	$0	$0	$0
Total People Sold	0	0	0	0
Total Sell Transactions	0	0	0	0
End Date	2025-05-22	2025-02-18	2024-08-20	2023-08-21

Adjust Filter Settings

Records found: 54

Page 1 of 3

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

Chief Financial Officer

• – –

2025-07-28

4

D

$17.16

$79,451

D/D

(4,630)

11,146

-

Chief Financial Officer

• – –

2025-07-28

4

A

$0.00

$0

D/D

15,776

15,776

-

Wang Jonathan Jian

– • –

2025-07-25

4

A

$0.00

$0

I/I

971,173

971,173

-

Wang Jonathan Jian

– • –

2025-07-25

4

A

$0.00

$0

D/D

143,832

143,832

-

Orbimed Genesis Gp Llc

Director

– • –

2025-07-25

4

A

$2.49

$208,191

I/I

83,611

287,885

-

– • –

2025-07-25

4

B

$29.90

$2,499,969

I/I

83,611

287,885

0.01

-

– • –

2025-07-25

4

OE

$0.00

$0

D/D

379

379

-

Stampacchia Otello

– • –

2025-07-25

4

B

$29.90

$7,999,924

I/I

267,556

454,982

0.01

-

Stampacchia Otello

– • –

2025-07-25

4

OE

$0.00

$0

D/D

379

379

-

Principal Accounting Officer

• – –

2025-07-25

4

A

$0.00

$0

D/D

3,051

3,051

-

Director

– • –

2023-08-04

4/A

A

$0.00

$0

I/I

153,121

5,582,144

-

Orbimed Genesis Gp Llc

Director

– • –

2023-08-04

4/A

A

$0.00

$0

I/I

153,121

5,582,144

-

Orbimed Genesis Gp Llc

Director

– • –

2023-08-04

4

A

$0.00

$0

I/I

153,121

2,251,218

-

Director

– • –

2023-08-04

4

A

$0.00

$0

I/I

153,121

2,251,218

-

Director

– • –

2022-06-24

4

S

$4.37

$803,975

I/I

(162,000)

2,098,097

-

Orbimed Genesis Gp Llc

Director

– • –

2022-06-24

4

S

$4.37

$803,975

I/I

(162,000)

2,098,097

-

Director

– • –

2022-06-23

4

S

$3.71

$86,884

I/I

(23,419)

1,936,097

-

Orbimed Genesis Gp Llc

Director

– • –

2022-06-23

4

S

$3.71

$86,884

I/I

(23,419)

1,936,097

-

Director

– • –

2022-06-22

4

S

$3.55

$237,161

I/I

(66,806)

1,912,678

-

Orbimed Genesis Gp Llc

Director

– • –

2022-06-22

4

S

$3.55

$237,161

I/I

(66,806)

1,912,678

-

Chief Business Officer

• – –

2022-01-18

4

OE

$2.94

$253,800

D/D

71,786

100,578

-

Zhang Xiaoyan Michelle

Chief Scientific Officer

• – –

2022-01-11

4

AS

$12.00

$11,568

D/D

(964)

44,475

-

Zhang Xiaoyan Michelle

Chief Scientific Officer

• – –

2022-01-11

4

OE

$2.15

$2,069

D/D

964

45,439

-

Zhang Xiaoyan Michelle

Chief Scientific Officer

• – –

2022-01-10

4

AS

$12.00

$432

D/D

(36)

44,475

-

Zhang Xiaoyan Michelle

Chief Scientific Officer

• – –

2022-01-10

4

OE

$2.15

$77

D/D

36

44,511

-

54 Records found	1 2 3	Page 1 of 3

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2025 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.